Essential Lean Body Mass: Vital for Life, Recovery, and Healing

This presentation will highlight the vital functions of lean body mass and explore the causes of lean mass decline. The mechanisms of sarcopenia, cachexia, and wasting will be discussed, compared, and contrasted. In addition, the participant will learn ways to identify individuals who have lost lean body mass with use of clinical and functional indicators.

Patient Simulation: Putting Malnutrition Screening, Assessment, Diagnosis, and Intervention into Practice

Course Objectives:

  • Determine a malnutrition diagnosis utilizing the Academy/A.S.P.E.N. clinical characteristics.
  • Access at least one muscle site for signs of malnutrition and demonstrate the use of a grip strength dynamometer.
  • Develop a nutrition care plan, recommending appropriate nutrition interventions for the malnourished patient.
  • Describe one functional measure for demonstrating improved nutritional status during follow-up.

Lean Body Mass: Navigating the Impact of Hospitalization on Recovery and Health Outcomes

Course Objectives:

  • Describe the impact and consequences of the loss of lean body mass during/after the hospital stay.
  • Define clinical and functional indicators of the loss of lean body mass.
  • Identify the relationship between loss of muscle function and hospital re-admissions.
  • Explain ways to maintain or improve essential lean body mass. One functional measure for demonstrating improved nutritional status during follow-up.

The International Conference on Frailty & Sarcopenia Research 2016

Philadelphia, Pennsylvania

April 28-29, 2016

The International Conference on Frailty & Sarcopenia Research will focus on:


  • Biology
  • Animal models
  • Preclinical studies
  • Clinical trials
  • Functional assessment
  • Biomarkers and imaging
  • New drug developments
  • Physical Exercise
  • Nutrition Intervention
  • Epidemiology
  • Other


  • Biology of frailty and aging
  • Physical frailty and age-related body composition modifications
  • Cognitive frailty
  • Frailty in clinical practice and public health
  • Clinical trials and therapeutics

8th International Conference on Cachexia, Sarcopenia and Muscle Wasting

Paris, France

December 4-6, 2015


‘Basic Science’ and ‘Clinical Science’ tracks:

  • Cachexia in Cancer, Heart Failure, COPD, CKD, and Stroke
  • Sarcopenia, Frailty and the Dysmobility Syndrome
  • Pathopsysiology and Epidemiology of Muscle Wasting
  • Body Composition Assessments
  • Screening, Diagnostic and Management
  • Special Populations
  • Clinical Trial Data

What is Sarcopenia?

Sarcopenia is a disease associated with the aging process.

Loss of muscle mass and strength, which in turn affects balance, gait and overall ability to perform tasks of daily living, are hallmark signs of this disease.

Aging in Motion

Alliance for Aging Research

The Facts about Sarcopenia


Sarcopenia is the progressive loss of skeletal muscle that comes with aging. Most people begin to lose modest amounts of muscle mass after age 30, but the resulting loss of strength increases exponentially with age.